Høgdall CK - Search Results

1

Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.

May T, Bernardini M, Lheureux S, Aben KKH, Bandera EV, Beckmann MW, Benitez J, Berchuck A, Bjørge L, Carney ME, Cramer DW, deFazio A, Dörk T, Eccles DM, Friedlander M, García MJ, Goode EL, Hein A, Høgdall CK, Jensen A, Johnatty S, Kennedy CJ, Kiemeney LA, Kjær SK, Kupryjańczyk J, Matsuo K, McGuire V, Modugno F, Paddock LE, Pejovic T, Phelan CM, Riggan MJ, Rodriguez-Antona C, Rothstein JH, Sieh W, Song H, Terry KL, van Altena AM, Vanderstichele A, Vergote I, Thomsen LCV, Webb PM, Wentzensen N, Wilkens LR, Ziogas A, Jiang H, Tone A; Ovarian Cancer Association and the Australian Ovarian Cancer Study Group. May T, et al. Among authors: hogdall ck. Can J Surg. 2023 Jun 27;66(3):E310-E320. doi: 10.1503/cjs.017020. Print 2023 May-Jun. Can J Surg. 2023. PMID: 37369443 Free PMC article.

2

Stability of YKL-40 concentration in blood samples.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Blaakjaer J, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Scand J Clin Lab Invest. 2000 Jul;60(4):247-51. doi: 10.1080/00365510050184886. Scand J Clin Lab Invest. 2000. PMID: 10943594

3

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.

Høgdall EV, Høgdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, Vuust J, Nørgaard-Pedersen B, Kjaer SK. Høgdall EV, et al. Among authors: hogdall ck. Anticancer Res. 2002 May-Jun;22(3):1859-64. Anticancer Res. 2002. PMID: 12168882

4

Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma.

Gronlund B, Hansen HH, Høgdall C, Engelholm SA. Gronlund B, et al. Cancer. 2002 Oct 15;95(8):1656-62. doi: 10.1002/cncr.10838. Cancer. 2002. PMID: 12365013 Free article.

5

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.

Høgdall EV, Høgdall CK, Blaakaer J, Heegaard NH, Glud E, Christensen L, Bock JE, Nørgaard-Pedersen B, Wiik A, Kjaer SK. Høgdall EV, et al. Among authors: hogdall ck. APMIS. 2002 Aug;110(7-8):545-53. doi: 10.1034/j.1600-0463.2002.11007805.x. APMIS. 2002. PMID: 12390412

6

K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study.

Høgdall EV, Høgdall CK, Blaakaer J, Christensen L, Bock JE, Vuust J, Glud E, Kjaer SK; Danish "Malova" Ovarian Cancer Study. Høgdall EV, et al. Among authors: hogdall ck. Gynecol Oncol. 2003 Apr;89(1):31-6. doi: 10.1016/s0090-8258(03)00005-2. Gynecol Oncol. 2003. PMID: 12694651

7

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Cancer. 2003 Jul 1;98(1):66-73. doi: 10.1002/cncr.11476. Cancer. 2003. PMID: 12833457 Free article.

8

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Oncol Rep. 2003 Sep-Oct;10(5):1535-8. Oncol Rep. 2003. PMID: 12883737

9

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.

Høgdall EV, Kjaer SK, Glud E, Christensen L, Blaakaer J, Vuust J, Bock JE, Norgaard-Pedersen B, Hogdall CK. Høgdall EV, et al. Among authors: hogdall ck. Anticancer Res. 2003 Jul-Aug;23(4):3397-404. Anticancer Res. 2003. PMID: 12926080

10

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.

Høgdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Cancer. 2004 Jun 1;100(11):2387-95. doi: 10.1002/cncr.20213. Cancer. 2004. PMID: 15160342 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page